Alps Advisors Inc Beyond Spring Inc. Transaction History

Alps Advisors Inc

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 11, 2022	SELL	$1.13 - $2.66 $45,832 - $107,889	-40,560 Closed	0 $0
Q1 2022 May 16, 2022	SELL	$1.68 - $5.01 $7,906 - $23,577	-4,706 Reduced 10.4%	40,560 $89,000
Q4 2021 Feb 09, 2022	BUY	$4.02 - $16.84 $181,969 - $762,279	45,266 New	45,266 $205,000

5.55M

26K

2.4K

Ticker BYSI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 38,928,900
Market Cap $66.6M
Description
BeyondSpring Inc., a clinical stage biopharmaceutical company, together with its subsidiaries, focuses on the development of cancer therapies. The company's lead asset is the Plinabulin, a selective immune-modulating microtubule-binding agent that has completed Phase III clinical trials for the prevention of chemotherapy-induced neutropenia; and...

Get notified when there are updates to the investment portfolio of Alps Advisors Inc, based on Form 13F filings with the SEC.

Stay updated on Alps Advisors Inc with notifications on news.